http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0770099-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D305-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
filingDate 1991-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f83c50e8d6ad108258a29c9f8fcb3184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c339a3ce0a4158d5662f5abbcd3c8b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51ae0bb1b16884e944158a8a3837e4ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a7ba86c425d1fe54a6a84ef9d906351
publicationDate 1995-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0770099-A
titleOfInvention Oxetanones
abstract (57) [Summary] (Modified) [Purpose] Novel oxetanones, methods for their preparation, pharmaceutical preparations containing such oxetanones, and the preparation of these oxetanones in the preparation of pharmaceutical preparations. Provide use. [Structure] The following formula I Wherein, Q is the following formula (R 3, R 4) NCO (X) n -CO- Q 1 (R 3, R 4) NCO-X'- Q 2 or , R 1 and R 2 represent an alkyl group substituted with a halogen atom, etc.], and novel pancreatic lipase-inhibiting oxetanones are prepared starting from the corresponding β-hydroxycarboxylic acid.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020527138-A
priorityDate 1990-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6P8U6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP16233
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP29183
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP50903
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100135601
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233227185
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54106407
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27657
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5406
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25702
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO88354
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ64425
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100157809
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID69060
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ02157
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00591
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009157

Total number of triples: 48.